Clinical Trial Update: First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating first-line antibiotic therapy for Helicobacter pylori-positive early-stage gastric diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Diffuse Large B-cell Lymphoma

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Gastric Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN